These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
325 related articles for article (PubMed ID: 23980919)
1. Correlation of headache frequency and psychosocial impairment in migraine: a cross-sectional study. Ruscheweyh R; Müller M; Blum B; Straube A Headache; 2014 May; 54(5):861-71. PubMed ID: 23980919 [TBL] [Abstract][Full Text] [Related]
2. A 3-month analysis of disability, quality of life, and disease course in patients with migraine. Raggi A; Leonardi M; Bussone G; D'Amico D Headache; 2013 Feb; 53(2):297-309. PubMed ID: 23094760 [TBL] [Abstract][Full Text] [Related]
3. Pain beliefs and perceptions inventory: a cross-sectional study in chronic and episodic migraine. Condello C; Piano V; Dadam D; Pinessi L; Lantéri-Minet M Headache; 2015 Jan; 55(1):136-48. PubMed ID: 25545038 [TBL] [Abstract][Full Text] [Related]
4. Validating Migraine-Specific Quality of Life Questionnaire v2.1 in episodic and chronic migraine. Bagley CL; Rendas-Baum R; Maglinte GA; Yang M; Varon SF; Lee J; Kosinski M Headache; 2012 Mar; 52(3):409-21. PubMed ID: 21929662 [TBL] [Abstract][Full Text] [Related]
5. Headache impact of chronic and episodic migraine: results from the American Migraine Prevalence and Prevention study. Buse D; Manack A; Serrano D; Reed M; Varon S; Turkel C; Lipton R Headache; 2012 Jan; 52(1):3-17. PubMed ID: 22106869 [TBL] [Abstract][Full Text] [Related]
6. Opioid use and dependence among persons with migraine: results of the AMPP study. Buse DC; Pearlman SH; Reed ML; Serrano D; Ng-Mak DS; Lipton RB Headache; 2012 Jan; 52(1):18-36. PubMed ID: 22268775 [TBL] [Abstract][Full Text] [Related]
7. Depression and anxiety: effect on the migraine-obesity relationship. Tietjen GE; Peterlin BL; Brandes JL; Hafeez F; Hutchinson S; Martin VT; Dafer RM; Aurora SK; Stein MR; Herial NA; Utley C; White L; Khuder SA Headache; 2007 Jun; 47(6):866-75. PubMed ID: 17578537 [TBL] [Abstract][Full Text] [Related]
8. Outcomes of a headache-specific cross-sectional multidisciplinary treatment program. Wallasch TM; Angeli A; Kropp P Headache; 2012; 52(7):1094-105. PubMed ID: 22703374 [TBL] [Abstract][Full Text] [Related]
9. Predicting disability and quality of life in a community-based sample of women with migraine headache. Kolotylo CJ; Broome ME Pain Manag Nurs; 2000 Dec; 1(4):139-51. PubMed ID: 11709867 [TBL] [Abstract][Full Text] [Related]
10. Cost of health care among patients with chronic and episodic migraine in Canada and the USA: results from the International Burden of Migraine Study (IBMS). Stokes M; Becker WJ; Lipton RB; Sullivan SD; Wilcox TK; Wells L; Manack A; Proskorovsky I; Gladstone J; Buse DC; Varon SF; Goadsby PJ; Blumenfeld AM Headache; 2011; 51(7):1058-77. PubMed ID: 21762134 [TBL] [Abstract][Full Text] [Related]
11. Negative impact of episodic migraine on a university population: quality of life, functional impairment, and comorbid psychiatric symptoms. Smitherman TA; McDermott MJ; Buchanan EM Headache; 2011 Apr; 51(4):581-9. PubMed ID: 21457242 [TBL] [Abstract][Full Text] [Related]
12. Examination of unmet treatment needs among persons with episodic migraine: results of the American Migraine Prevalence and Prevention (AMPP) Study. Lipton RB; Buse DC; Serrano D; Holland S; Reed ML Headache; 2013 Sep; 53(8):1300-11. PubMed ID: 23879870 [TBL] [Abstract][Full Text] [Related]
13. Persistent frequent nausea is associated with progression to chronic migraine: AMPP study results. Reed ML; Fanning KM; Serrano D; Buse DC; Lipton RB Headache; 2015 Jan; 55(1):76-87. PubMed ID: 25250833 [TBL] [Abstract][Full Text] [Related]
14. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues. Cady R; Schreiber C Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501 [TBL] [Abstract][Full Text] [Related]
15. Are depressive symptomatology, self-efficacy, and perceived social support related to disability and quality of life in patients with chronic migraine associated to medication overuse? Data from a cross-sectional study. D'Amico D; Grazzi L; Bussone G; Curone M; Di Fiore P; Usai S; Leonardi M; Giovannetti AM; Schiavolin S; Raggi A Headache; 2015 May; 55(5):636-45. PubMed ID: 25913219 [TBL] [Abstract][Full Text] [Related]
16. Sleep disturbance and affective comorbidity among episodic migraineurs. Walters AB; Hamer JD; Smitherman TA Headache; 2014 Jan; 54(1):116-24. PubMed ID: 23808359 [TBL] [Abstract][Full Text] [Related]
17. Topiramate treatment of chronic migraine: a randomized, placebo-controlled trial of quality of life and other efficacy measures. Silberstein S; Lipton R; Dodick D; Freitag F; Mathew N; Brandes J; Bigal M; Ascher S; Morein J; Wright P; Greenberg S; Hulihan J Headache; 2009 Sep; 49(8):1153-62. PubMed ID: 19719543 [TBL] [Abstract][Full Text] [Related]
18. The impact of topiramate on health-related quality of life indicators in chronic migraine. Dodick DW; Silberstein S; Saper J; Freitag FG; Cady RK; Rapoport AM; Mathew NT; Hulihan J; Crivera C; Rupnow MF; Mao L; Finlayson G; Greenberg SJ Headache; 2007; 47(10):1398-408. PubMed ID: 18052949 [TBL] [Abstract][Full Text] [Related]
19. Factors associated with burden of primary headache in a specialty clinic. Cassidy EM; Tomkins E; Hardiman O; O'Keane V Headache; 2003 Jun; 43(6):638-44. PubMed ID: 12786924 [TBL] [Abstract][Full Text] [Related]
20. Healthcare resource utilization and direct costs associated with frequent nausea in episodic migraine: results from the American Migraine Prevalence and Prevention (AMPP) Study. Lipton RB; Buse DC; Saiers J; Serrano D; Reed ML J Med Econ; 2013; 16(4):490-9. PubMed ID: 23356422 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]